Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a leading developer of spider silk-based ...

Chief Minister Himanta Biswa Sarma on Thursday asserted that the upcoming investment summit in the state -- 'Advantage Assam' is poised to position the state as a hub of innovation and ...

For nature-lovers who dislike cold weather, or who may not be able to physically participate in outdoor winter activities, virtual programming can serve as the prescription for cabin fever. The ...

FERMENTALG - Fermentalg accelerates its transformation and structures its business development to support its financial ...

Genetic researcher Nathan Clark spoke about research his team at the University of Pittsburgh conducted on evolutionary ...

Their new worm and jellyfish robots are built around the transformative concept of “embodied energy,” where integrating the power source into the robot’s structure reduces w ...

State Key Laboratory of Freshwater Ecology and Biotechnology, Key Laboratory of Lake and Watershed Science for Water Security, Institute of Hydrobiology, Chinese Academy of Sciences, Donghu South Road ...

State Key Laboratory of Environmental Aquatic Chemistry, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China University of Chinese Academy of Sciences, ...

Police have released photos of a group who may have information on the alleged assault of a young lifeguard at an aquatic centre. A 19-year-old lifeguard was patrolling Casey Aquatic Recreation ...

Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...

The biotech firm's mRNA-1018 candidate posted positive results in a Phase 1/2 study launched in 2023. Moderna plans to move mRNA-1018 to a Phase 3 trial. Shares of Moderna (MRNA) took off Tuesday ...

In 2019, Stan­ford Uni­ver­si­ty pro­fes­sor Irv Weiss­man and a col­league pub­lished a pa­per that rep­re­sent­ed a new way to tar­get some ag­gres­sive can­cers.